Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Hemophilia - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Hemophilia for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Hemophilia from 2010-2020.Hemophilia is a bleeding disorder that slows the blood clotting process. People with this condition experience prolonged bleeding or oozing following an injury, surgery, or having a tooth pulled. The major types of this condition are hemophilia A (also known as classic hemophilia or factor VIII deficiency) and hemophilia B (also known as Christmas disease or factor IX deficiency). Although the two types have very similar signs and symptoms, they are caused by mutations in different genes. Gene therapy might eventually help people with hemophilia begin producing their own clotting factor, alleviating the need for or reducing the number of weekly infusions.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Hemophilia for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Hemophilia
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Hemophilia Market
• Global Epidemiology of Hemophilia Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Hemophilia Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Hemophilia (2011-2020)
• Table 7: Hemophilia Global Market Size (USD Millions), (2011-2014)
• Table 8: Hemophilia Global Market Size (USD Millions), (2015-2020)
• Table 9: Hemophilia US Market Size (USD Millions), (2011-2014)
• Table 10: Hemophilia US Market Size (USD Millions), (2015-2020)
• Table 11: Hemophilia United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Hemophilia Germany Market Size (USD Millions), (2015-2020)
• Table 13: Hemophilia United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Hemophilia United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Hemophilia France Market Size (USD Millions), (2011-2014)
• Table 16: Hemophilia France Market Size (USD Millions), (2015-2020)
• Table 17: Hemophilia Italy Market Size (USD Millions), (2011-2014)
• Table 18: Hemophilia Italy Market Size (USD Millions), (2015-2020)
• Table 19: Hemophilia Spain Market Size (USD Millions), (2011-2014)
• Table 20: Hemophilia Spain Market Size (USD Millions), (2015-2020)
• Table 21: Hemophilia Japan Market Size (USD Millions), (2011-2014)
• Table 22: Hemophilia Japan Market Size (USD Millions), (2015-2020)
• Table 23: Hemophilia ROW Market Size (USD Millions), (2011-2014)
• Table 24: Hemophilia ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Hemophilia Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Hemophilia (2011-2020)
• Figure 3: Hemophilia Global Market Size (USD Millions), (2011-2014)
• Figure 4: Hemophilia Global Market Size (USD Millions), (2015-2020)
• Figure 5: Hemophilia US Market Size (USD Millions), (2011-2014)
• Figure 6: Hemophilia US Market Size (USD Millions), (2015-2020)
• Figure 7: Hemophilia Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Hemophilia Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Hemophilia United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Hemophilia United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Hemophilia France Market Size (USD Millions), (2011-2014)
• Figure 12: Hemophilia France Market Size (USD Millions), (2015-2020)
• Figure 13: Hemophilia Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Hemophilia Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Hemophilia Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Hemophilia Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Hemophilia Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Hemophilia Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Hemophilia ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Hemophilia ROW Market Size (USD Millions), (2015-2020)
